Dow Down 0.25% Nasdaq Down 0.26%

Immunomedics Inc. (IMMU)

-NasdaqGM
3.20 0.05(1.54%) Aug 28, 4:00PM EDT
Prev Close:3.25
Open:3.22
Bid:3.13 x 600
Ask:3.51 x 100
1y Target Est:7.00
Beta:0.71
Next Earnings Date:N/A
Day's Range:3.14 - 3.24
52wk Range:3.04 - 7.35
Volume:793,158
Avg Vol (3m):528,861
Market Cap:297.96M
P/E (ttm):N/A
EPS (ttm):-0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMMU

Comparison

Symbol% ChgMkt Cap
IMMUDown 1.54%297.96M
BIIB80.58B
GSK117.39B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):33.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.48
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback